Samsara BioCapital, 10% Owner: Neurogene NGNE Buy · Filed 24/11/27

Trade details

Type: Insider buy
Amount: $280,986.03
Shares · price: 10,803 sh · $26.01 a share
Held after: 1,699,908 sh
Stock: Neurogene NGNE
Person: Samsara BioCapital10% Owner
Trade date: 24/11/26
Filed: 24/11/27
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +0.6%

Neurogene trades, last 26 weeks

What else happened in Neurogene around then

Filed or reported within 30 days of the trade day · 24/10/27~24/12/26

Samsara BioCapital's recent trades

Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
Samsara BioCapital10% Owner
BuyMineralys Therapeutics
Buy
Mineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26